JINARC cpr 60 mg/30 mg 56 pce

7680656760096 CH-65676 C03XA01 05.02.0.

Reimbursement limitations:

JINARC.01

Après la garantie de prise en charge des frais par l’assureur-maladie après consultation du médecin-conseil. …

JINARC cpr 60 mg/30 mg 56 pce
JINARC cpr 60 mg/30 mg 56 pce
JINARC cpr 60 mg/30 mg 56 pce
1 / 3
google

Details

Product number
6567604
CPT
-
Packaging group
28 + 28
Unit
Tablette(n)
Composition
A): tolvaptanum 60 mg, hydroxypropylcellulosum, lactosum monohydricum 16.838 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132 pro compresso. B): tolvaptanum 30 mg, hydroxypropylcellulosum, lactosum monohydricum 73.826 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132 pro compresso.

Articles (1)

Jinarc 60 mg + 30 mg, Tabletten
Tabletten
28 + 28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/08/2025
Patient information leaflet
Français
26/08/2025
Patient information leaflet
Italien
26/08/2025
Professional SmPC
Allemand
26/08/2025
Professional SmPC
Français
26/08/2025
Professional SmPC
Italien
26/08/2025

Detailed composition

Substance Quantity Type Category
B
30.0 MG Substance Wirkstoff (Principe actif)
A
60.0 MG Substance Wirkstoff (Principe actif)
A
- Substance HNIDK
B
- Substance HNIDK
A
16.838 MG Substance HBESI
B
73.826 MG Substance HBESI
A
- Substance HNIDK
B
- Substance HNIDK
B
- Substance HNIDK
A
- Substance HNIDK
A
- Substance HNIDK
B
- Substance HNIDK
B
- Substance HNIDK
A
- Substance HNIDK
A
- Substance FIMDK
B
- Substance FIMDK

Reimbursement information

Public price
CHF 1418.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2016

Authorization holder

Otsuka Pharmaceutical

8152 Opfikon

Authorization information

Swissmedic authorization number
65676
Drug name
Jinarc, Tabletten
Galenic form
TAB
ATC Code
C03XA01
Authorization status
Z
Dispensation category
A
First authorization
21/04/2016
Authorization expiration date
31/12/9999
IT number
05.02.0.
Domain
Human medicine
Field of application
Verlangsamung der Progression der Zystenentwicklung und Niereninsuffizienz bei autosomal-dominanter polyzystischer Nierenerkrankung

Packaging details

Description (FR)
JINARC cpr 60 mg/30 mg 56 pce
Description (DE)
JINARC Tabl 60 mg/30 mg 56 Stk
Market launch
21/04/2016
Narcotic (BTM)
No

Other packaging sizes

JINARC cpr 15 mg 28 pce
28 TABL
View
JINARC cpr 30 mg 28 pce
28 TABL
View
JINARC cpr 45 mg/15 mg 56 pce
28 + 28 TABL
View
JINARC cpr 90 mg/30 mg 56 pce
28 + 28 TABL
View